Artykuły w czasopismach na temat „Myocardial hypertrophy”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Myocardial hypertrophy”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Tang, Xin, Lihong Pan, Shuang Zhao, Feiyue Dai, Menglin Chao, Hong Jiang, Xuesong Li i in. "SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)–Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation". Circulation 141, nr 12 (24.03.2020): 984–1000. http://dx.doi.org/10.1161/circulationaha.119.042336.
Pełny tekst źródłaXue, Honghong, Hongtao Shi, Fan Zhang, Hao Li, Chao Li i Qinghua Han. "RIP3 Contributes to Cardiac Hypertrophy by Influencing MLKL-Mediated Calcium Influx". Oxidative Medicine and Cellular Longevity 2022 (14.04.2022): 1–15. http://dx.doi.org/10.1155/2022/5490553.
Pełny tekst źródłaParker, Thomas G., i James N. Tsoporis. "Induction of S100β in Myocardium: An Intrinsic Inhibitor of Cardiac Hypertrophy". Canadian Journal of Applied Physiology 23, nr 4 (1.08.1998): 377–89. http://dx.doi.org/10.1139/h98-022.
Pełny tekst źródłaTasnic, Mihail, Valeriu Revenco i Ilia Catereniuc. "Correlations of myocardial bridges with left ventricle myocardial hypertrophy and prepontin coronary atherosclerosis". Moldovan Medical Journal 64, nr 5 (grudzień 2021): 21–26. http://dx.doi.org/10.52418/moldovan-med-j.64-5.21.04.
Pełny tekst źródłaOuattara, Alexandre, Olivier Langeron, Rachid Souktani, Stéphane Mouren, Pierre Coriat i Bruno Riou. "Myocardial and Coronary Effects of Propofol in Rabbits with Compensated Cardiac Hypertrophy". Anesthesiology 95, nr 3 (1.09.2001): 699–707. http://dx.doi.org/10.1097/00000542-200109000-00024.
Pełny tekst źródłaLu, Dan, Jizheng Wang, Jing Li, Feifei Guan, Xu Zhang, Wei Dong, Ning Liu, Shan Gao i Lianfeng Zhang. "Meox1 accelerates myocardial hypertrophic decompensation through Gata4". Cardiovascular Research 114, nr 2 (16.11.2017): 300–311. http://dx.doi.org/10.1093/cvr/cvx222.
Pełny tekst źródłaChiu, Chiung-Zuan, Bao-Wei Wang, Tun-Hui Chung i Kou-Gi Shyu. "Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes". Clinical Science 119, nr 7 (22.06.2010): 273–82. http://dx.doi.org/10.1042/cs20100084.
Pełny tekst źródłaLiu, Xiuhua, Tianbo Li, Sheng Sun, Feifei Xu i Yiguang Wang. "Role of myofibrillogenesis regulator-1 in myocardial hypertrophy". American Journal of Physiology-Heart and Circulatory Physiology 290, nr 1 (styczeń 2006): H279—H285. http://dx.doi.org/10.1152/ajpheart.00247.2005.
Pełny tekst źródłaLv, Shichao, Qiang Wang, Meifang Wu, Meng Li, Xiaojing Wang, Ling Xu i Junping Zhang. "QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats". Evidence-Based Complementary and Alternative Medicine 2021 (16.06.2021): 1–10. http://dx.doi.org/10.1155/2021/5536723.
Pełny tekst źródłaZheng, Xi, Fuxiang Su, Ze Kang, Jingyuan Li, Chenyang Zhang, Yujia Zhang i Liying Hao. "Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial Hypertrophy". Cardiovascular Therapeutics 2022 (2.05.2022): 1–13. http://dx.doi.org/10.1155/2022/2715084.
Pełny tekst źródłaLiu, Yao-Lung, Chiu-Ching Huang, Chiz-Chung Chang, Che-Yi Chou, Shih-Yi Lin, I.-Kuan Wang, Dennis Jine-Yuan Hsieh, Gwo-Ping Jong, Chih-Yang Huang i Chao-Min Wang. "Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment". Cardiorenal Medicine 5, nr 2 (2015): 79–88. http://dx.doi.org/10.1159/000371454.
Pełny tekst źródłaNakamura, Teruya, Kunio Matsumoto, Shinya Mizuno, Yoshiki Sawa, Hikaru Matsuda i Toshikazu Nakamura. "Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts". American Journal of Physiology-Heart and Circulatory Physiology 288, nr 5 (maj 2005): H2131—H2139. http://dx.doi.org/10.1152/ajpheart.01239.2003.
Pełny tekst źródłaKoga, Kiyokazu, Agnes Kenessey i Kaie Ojamaa. "Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy". American Journal of Physiology-Heart and Circulatory Physiology 304, nr 2 (15.01.2013): H282—H293. http://dx.doi.org/10.1152/ajpheart.00595.2012.
Pełny tekst źródłaLeontyeva, I. V., N. V. Shcherbakova, E. P. Kalachanova, S. A. Thermosesov i V. S. Sukhorukov. "Hypertrophic cardiomyopathy caused by mutations in the <I>PRKAG2</I> gene". Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 67, nr 4 (21.09.2022): 99–107. http://dx.doi.org/10.21508/1027-4065-2022-67-4-99-107.
Pełny tekst źródłaJi, Xiao-Bing, Xiu-Rong Li, Hao-Ding, Qi Sun, Yang Zhou, Ping Wen, Chun-Sun Dai i Jun-Wei Yang. "Inhibition of Uncoupling Protein 2 Attenuates Cardiac Hypertrophy Induced by Transverse Aortic Constriction in Mice". Cellular Physiology and Biochemistry 36, nr 5 (2015): 1688–98. http://dx.doi.org/10.1159/000430142.
Pełny tekst źródłaChernykh, N. Yu, A. A. Tarasova, O. S. Groznova i I. M. Shigabeev. "Left ventricular myocardial strain and electrocardiographic changes in children with hypertrophic cardiomyopathy". Meditsinskiy sovet = Medical Council, nr 11 (12.08.2021): 124–32. http://dx.doi.org/10.21518/2079-701x-2021-11-124-132.
Pełny tekst źródłaAluja, David, Sara Delgado-Tomás, Marisol Ruiz-Meana, José A. Barrabés i Javier Inserte. "Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy". International Journal of Molecular Sciences 23, nr 8 (7.04.2022): 4103. http://dx.doi.org/10.3390/ijms23084103.
Pełny tekst źródłaWang, Hui, Yuqin Zhang, Shuwen Guo, Jiani Wu, Wang’ou Lin, Binyue Zhang, Pengfei Feng i in. "Effects of Yiqi Huoxue Decoction on Post-Myocardial Infarction Cardiac Nerve Remodeling and Cardiomyocyte Hypertrophy in Rats". Evidence-Based Complementary and Alternative Medicine 2021 (21.08.2021): 1–16. http://dx.doi.org/10.1155/2021/5168574.
Pełny tekst źródłaChen, Chao-Yi, Jyh-Gang Leu, Kuan-Yu Lin, Chin-Yu Shih i Yao-Jen Liang. "Serotonin receptor subtype-2B signaling is associated with interleukin-18-induced cardiomyoblast hypertrophy in vitro". Asian Biomedicine 16, nr 2 (1.04.2022): 79–87. http://dx.doi.org/10.2478/abm-2022-0010.
Pełny tekst źródłaXia, Huiting, Aqeela Zahra, Meng Jia, Qun Wang, Yunfu Wang, Susan L. Campbell i Jianping Wu. "Na+/H+ Exchanger 1, a Potential Therapeutic Drug Target for Cardiac Hypertrophy and Heart Failure". Pharmaceuticals 15, nr 7 (15.07.2022): 875. http://dx.doi.org/10.3390/ph15070875.
Pełny tekst źródłaBishop, Sanford P. "The Myocardial Cell: Normal Growth, Cardiac Hypertrophy and Response to Injury". Toxicologic Pathology 18, nr 4a (styczeń 1990): 438–53. http://dx.doi.org/10.1177/0192623390004part_102.
Pełny tekst źródłaNakata, Yohei, Muneo Yoshibayashi, Toshiya Yonemura, Shinji Uemoto, Yukihiro Inomata, Koichi Tanaka i Kenshi Furusho. "TACROLIMUS AND MYOCARDIAL HYPERTROPHY". Transplantation 69, nr 9 (maj 2000): 1960–62. http://dx.doi.org/10.1097/00007890-200005150-00039.
Pełny tekst źródłaSuzuki, Jun-ichi, Hiroki Sato, Makoto Kaneko, Asuka Yoshida, Norio Aoyama, Shouta Akimoto, Kouji Wakayama i in. "Periodontitis and myocardial hypertrophy". Hypertension Research 40, nr 4 (10.11.2016): 324–28. http://dx.doi.org/10.1038/hr.2016.146.
Pełny tekst źródłaNakagami, Hironori, i James K. Liao. "Statins and myocardial hypertrophy". Coronary Artery Disease 15, nr 5 (sierpień 2004): 247–50. http://dx.doi.org/10.1097/01.mca.0000130229.18685.b9.
Pełny tekst źródłaSugden, Peter H. "Signaling in Myocardial Hypertrophy". Circulation Research 84, nr 6 (2.04.1999): 633–46. http://dx.doi.org/10.1161/01.res.84.6.633.
Pełny tekst źródłaHirsch, Alan T., John A. Opsahl, Mary M. Lunzer i Stephen A. Katz. "Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarction". American Journal of Physiology-Heart and Circulatory Physiology 276, nr 6 (1.06.1999): H1818—H1826. http://dx.doi.org/10.1152/ajpheart.1999.276.6.h1818.
Pełny tekst źródłaChen, Yintao, Ye Chang, Naijin Zhang, Xiaofan Guo, Guozhe Sun i Yingxian Sun. "Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway". Cellular Physiology and Biochemistry 46, nr 3 (2018): 1009–18. http://dx.doi.org/10.1159/000488832.
Pełny tekst źródłaHan, Jibo, Shanshan Dai, Lingfeng Zhong, Xiaowen Shi, Xiaoxi Fan, Xin Zhong, Wante Lin i in. "GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis". Hypertension 79, nr 11 (listopad 2022): 2505–18. http://dx.doi.org/10.1161/hypertensionaha.122.20004.
Pełny tekst źródłaShen, Linyuan, Mailin Gan, Zhengdong Tan, Dongmei Jiang, Yanzhi Jiang, Mingzhou Li, Jinyong Wang, Xuewei Li, Shunhua Zhang i Li Zhu. "A Novel Class of tRNA-Derived Small Non-Coding RNAs Respond to Myocardial Hypertrophy and Contribute to Intergenerational Inheritance". Biomolecules 8, nr 3 (16.07.2018): 54. http://dx.doi.org/10.3390/biom8030054.
Pełny tekst źródłaTsuda, Takeshi. "Clinical Assessment of Ventricular Wall Stress in Understanding Compensatory Hypertrophic Response and Maladaptive Ventricular Remodeling". Journal of Cardiovascular Development and Disease 8, nr 10 (29.09.2021): 122. http://dx.doi.org/10.3390/jcdd8100122.
Pełny tekst źródłaDung, Van Hung, Pham Thanh Binh, Nguyen Tien Hoa i Bui Minh Trang. "Case report: Bilateral hypertrophic obstructive cardiomyophathy associated with myocardial bridge". Tạp chí Phẫu thuật Tim mạch và Lồng ngực Việt Nam 39 (31.10.2022): 122–25. http://dx.doi.org/10.47972/vjcts.v39i.810.
Pełny tekst źródłaTennant, Bryn. "Small Animal Review". Companion Animal 25, nr 5 (2.06.2020): 110. http://dx.doi.org/10.12968/coan.2020.0043.
Pełny tekst źródłaStrøm, Claes C., Mogens Kruhøffer, Steen Knudsen, Frank Stensgaard-Hansen, Thomas E. N. Jonassen, Torben F. Ørntoft, Stig Haunsø i Søren P. Sheikh. "Identification of a Core Set of Genes That Signifies Pathways Underlying Cardiac Hypertrophy". Comparative and Functional Genomics 5, nr 6-7 (2004): 459–70. http://dx.doi.org/10.1002/cfg.428.
Pełny tekst źródłaLorén, Christina, Christen Dahl, Lan Do, Vibeke Almaas, Odd Geiran, Stellan Mörner i Urban Hellman. "Low Molecular Mass Myocardial Hyaluronan in Human Hypertrophic Cardiomyopathy". Cells 8, nr 2 (29.01.2019): 97. http://dx.doi.org/10.3390/cells8020097.
Pełny tekst źródłaBasargina, E. N., V. S. Ermolenko i I. V. Sil’nova. "Myocardial hypertrophy in infants in pediatric practice". Kazan medical journal 96, nr 4 (15.08.2015): 647–53. http://dx.doi.org/10.17750/kmj2015-647.
Pełny tekst źródłaZhu, Huiping, Liutong Pan, Yuanting Dai, Dan Zheng i Shasha Cai. "Role of TLR4/MyD88 Signaling Pathway in the Occurrence and Development of Uremia-Induced Myocardial Hypertrophy and Possible Mechanism". Evidence-Based Complementary and Alternative Medicine 2021 (13.10.2021): 1–9. http://dx.doi.org/10.1155/2021/7883643.
Pełny tekst źródłaCalamaras, Timothy D., Robert A. Baumgartner, Mark J. Aronovitz, Angela L. McLaughlin, Kelly Tam, Daniel A. Richards, Craig W. Cooper i in. "Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload". American Journal of Physiology-Heart and Circulatory Physiology 316, nr 1 (1.01.2019): H145—H159. http://dx.doi.org/10.1152/ajpheart.00029.2018.
Pełny tekst źródłaZhao, Mingyue, Lihui Lu, Song Lei, Hua Chai, Siyuan Wu, Xiaoju Tang, Qinxue Bao, Li Chen, Wenchao Wu i Xiaojing Liu. "Inhibition of Receptor Interacting Protein Kinases Attenuates Cardiomyocyte Hypertrophy Induced by Palmitic Acid". Oxidative Medicine and Cellular Longevity 2016 (2016): 1–13. http://dx.doi.org/10.1155/2016/1451676.
Pełny tekst źródłaMing, Sitong, Mo Kan, Liu Liu, Zhuang Zhang, Xiaoran Liu, Yaxin Liu, Zhen Li i in. "Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA". Evidence-Based Complementary and Alternative Medicine 2022 (7.09.2022): 1–17. http://dx.doi.org/10.1155/2022/3188292.
Pełny tekst źródłaSharma, Jayendra, William Hellenbrand, Charles Kleinman i Ralph Mosca. "Symptomatic myocardial bridges in children: a case report with review of literature". Cardiology in the Young 21, nr 5 (23.06.2011): 490–94. http://dx.doi.org/10.1017/s1047951111000849.
Pełny tekst źródłaJain, Mohit, Ronglih Liao, Bruno K. Podesser, Soeun Ngoy, Carl S. Apstein i Franz R. Eberli. "Influence of gender on the response to hemodynamic overload after myocardial infarction". American Journal of Physiology-Heart and Circulatory Physiology 283, nr 6 (1.12.2002): H2544—H2550. http://dx.doi.org/10.1152/ajpheart.00338.2002.
Pełny tekst źródłaKatz, Stephen A., John A. Opsahl, Shane E. Wernsing, Lynn M. Forbis, Juline Smith i Lois J. Heller. "Myocardial renin is neither necessary nor sufficient to initiate or maintain ventricular hypertrophy". American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 278, nr 3 (1.03.2000): R578—R586. http://dx.doi.org/10.1152/ajpregu.2000.278.3.r578.
Pełny tekst źródłaSarkar, Sagartirtha, Douglas W. Leaman, Sudhiranjan Gupta, Parames Sil, David Young, Annitta Morehead, Debabrata Mukherjee i in. "Cardiac Overexpression of Myotrophin Triggers Myocardial Hypertrophy and Heart Failure in Transgenic Mice". Journal of Biological Chemistry 279, nr 19 (16.02.2004): 20422–34. http://dx.doi.org/10.1074/jbc.m308488200.
Pełny tekst źródłaLiu, Lei, Chao Wang, Dianjun Sun, Shuangquan Jiang, Hong Li, Weihua Zhang, Yajun Zhao i in. "Calhex231 Ameliorates Cardiac Hypertrophy by Inhibiting Cellular Autophagy in Vivo and in Vitro". Cellular Physiology and Biochemistry 36, nr 4 (2015): 1597–612. http://dx.doi.org/10.1159/000430322.
Pełny tekst źródłaIswara, Raja Al Fath Widya, Arif Rahman Sadad, Intarniati Nur Rohmah i Sigid Kirana Lintang Bhima. "Kematian Mendadak Akibat Kardiomiopati Hipertrofi Pada Dewasa Muda". Medica Hospitalia : Journal of Clinical Medicine 7, nr 2 (19.11.2020): 470–75. http://dx.doi.org/10.36408/mhjcm.v7i2.522.
Pełny tekst źródłaSui, Xin, Na Li, Xiaozheng Shi, Xiaohua Li, Dong Han, Zhidong Qiu, Yue Deng i Guangwei Sun. "Pinocembrin Protects Cardiomyocytes Against Isoproterenol-Induced Hypertrophy". Natural Product Communications 16, nr 8 (sierpień 2021): 1934578X2110332. http://dx.doi.org/10.1177/1934578x211033216.
Pełny tekst źródłaGarcía-Díaz, Lutgardo, Félix Coserria i Guillermo Antiñolo. "Hypertrophic Cardiomyopathy due to Mitochondrial Disease: Prenatal Diagnosis, Management, and Outcome". Case Reports in Obstetrics and Gynecology 2013 (2013): 1–4. http://dx.doi.org/10.1155/2013/472356.
Pełny tekst źródłaBupha-Intr, Tepmanas, Jeffrey W. Holmes i Paul M. L. Janssen. "Induction of hypertrophy in vitro by mechanical loading in adult rabbit myocardium". American Journal of Physiology-Heart and Circulatory Physiology 293, nr 6 (grudzień 2007): H3759—H3767. http://dx.doi.org/10.1152/ajpheart.01267.2006.
Pełny tekst źródłaMorgan, Howard E. "Signal transduction in myocardial hypertrophy." Keio Journal of Medicine 39, nr 1 (1990): 1–5. http://dx.doi.org/10.2302/kjm.39.1.
Pełny tekst źródłaZhang, Jianyi. "Myocardial Energetics In Cardiac Hypertrophy". Clinical and Experimental Pharmacology and Physiology 29, nr 4 (kwiecień 2002): 351–59. http://dx.doi.org/10.1046/j.1440-1681.2002.03657.x.
Pełny tekst źródła